Cannabis and acid reflux have a surprisingly contradictory relationship. In controlled lab settings, THC appears to reduce one of the main triggers of reflux episodes, yet large hospital studies consistently find that cannabis users are more likely to develop esophagitis and other reflux complications than nonusers. The disconnect between what happens in a single-dose experiment and what happens over months or years of regular use is where the real story lies, and it matters for anyone managing gastroesophageal reflux disease (GERD) who also uses cannabis.
What THC Does to the Valve That Keeps Acid Down
Most acid reflux isn’t caused by a permanently weak valve at the bottom of the esophagus. It happens because of brief, spontaneous relaxations of that valve, called transient lower esophageal sphincter relaxations. These relaxations allow stomach acid to splash upward. In both animal studies and a small human trial, THC reduced the frequency of these relaxations after a meal. In the human volunteers, the reduction was significant during the first hour after eating, and there was a trend toward fewer reflux episodes as well, though that part didn’t reach statistical significance.1PubMed Central. Effect of delta9-tetrahydrocannabinol, a cannabinoid receptor agonist, on the triggering of transient lower oesophageal sphincter relaxations in dogs and humans An earlier animal study using a different cannabinoid receptor agonist found an even more dramatic effect, cutting those spontaneous relaxations by about 80% after a stomach-filling load. When the researchers blocked the CB1 receptor specifically, the effect disappeared, confirming it was receptor-driven.2PubMed. Cannabinoid receptor agonism inhibits transient lower esophageal sphincter relaxations and reflux in dogs
On the surface, this sounds like THC should be good news for reflux. But the same study that showed fewer spontaneous relaxations also found that THC significantly lowered baseline pressure in the esophageal sphincter itself.1PubMed Central. Effect of delta9-tetrahydrocannabinol, a cannabinoid receptor agonist, on the triggering of transient lower oesophageal sphincter relaxations in dogs and humans A weaker sphincter at rest means that even though it relaxes less often on its own, it may not hold acid back as effectively during other triggers, like bending over, lying down, or coughing. This is where the gap between a controlled lab dose and real-world use starts to open.
What Hospital Data Shows About Cannabis Users and Reflux
When researchers look at large groups of patients rather than individual doses, the picture flips. A study using U.S. national hospital records found that cannabis users with GERD were roughly 80% more likely to have reflux esophagitis and about 23% more likely to have Barrett’s esophagus compared to nonusers, even after adjusting for other risk factors.3PubMed Central. Marijuana Use as a Lifestyle Factor Associated With Gastroesophageal Reflux Disease (GERD) Complications A separate analysis of the National Inpatient Sample found a similar pattern: cannabis users had nearly twice the rate of esophagitis compared to nonusers, with adjusted odds of esophagitis about 34% higher even after accounting for confounders.4PubMed. Association of Cannabis Use with Complications Among Patients with Gastroesophageal Reflux Disease: Insights from National Inpatient Sample
These are observational studies, so they can’t prove that cannabis caused the extra damage. Cannabis users may also be more likely to smoke tobacco, drink alcohol, eat late at night, or skip medications. But the associations held after statistical adjustment for many of those variables, and two independent datasets pointed in the same direction. That makes the signal hard to dismiss as pure coincidence.
Barrett’s esophagus deserves special attention here. It’s a condition where the normal lining of the esophagus gets replaced by a different cell type better suited to withstand acid, and it’s a known precursor to esophageal cancer.5PubMed Central. Does Smoking Cannabis Increase the Risk of Barrett’s Esophagus? The fact that cannabis users showed higher rates of Barrett’s in the GERD population suggests chronic, low-level acid exposure over time, not the kind of thing a single-dose experiment would capture.
Slowed Gastric Emptying and Why It Matters
One plausible explanation for why chronic cannabis use worsens reflux is its effect on how quickly your stomach empties. Early research suggested THC didn’t change gastric emptying much, but more recent work has found that cannabinoid agonists slow gut motility and can delay emptying of solid food in healthy people.6PubMed Central. Marijuana Use in Patients with Symptoms of Gastroparesis: Prevalence, Patient Characteristics, and Perceived Benefit Slower emptying means food and acid sit in the stomach longer, increasing the window for reflux episodes. If you’re using cannabis regularly, this delay could be chronic rather than occasional.
The irony is that many cannabis users report using it specifically because it helps with nausea and stomach discomfort. And for short-term nausea relief, the anti-emetic properties of THC are well-documented. But the same mechanism that suppresses the urge to vomit also slows down the normal movement of food through the digestive system. For someone with reflux, this can create a frustrating loop: the cannabis eases the feeling of nausea while the slower emptying produces more opportunities for acid to creep upward.
How Smoking and Vaping Create Their Own Problems
The route of administration adds a layer that has nothing to do with cannabinoid pharmacology. Smoking cannabis involves hot smoke passing through the esophagus, and inhaling deeply and holding the breath raises intra-abdominal pressure. Coughing fits after a hit do the same. Any spike in abdominal pressure pushes stomach contents toward the esophageal sphincter. Cannabis has been associated with gastrointestinal disorders including GERD in review literature that considers these combined exposures.7PubMed Central. Cannabis Use and Associated Gastrointestinal Disorders: A Literature Review
Vaping doesn’t eliminate these risks. A documented case of severe esophagitis (graded Los Angeles C, meaning extensive damage involving multiple mucosal folds) occurred in a patient who had been vaping THC and nicotine heavily for about two months. Biopsies showed granulation tissue with both acute and chronic inflammation.8PubMed Central. Vaping-associated esophagitis While nicotine likely played a role in that case, the finding reinforces that inhalation as a delivery method carries its own mucosal injury potential, separate from whatever the cannabinoids themselves are doing at the receptor level.
Anyone who smokes cannabis with tobacco (as in spliffs or blunts) is introducing nicotine into the equation as well. Nicotine is a well-established reflux trigger on its own, relaxing the lower esophageal sphincter and reducing saliva production. Combining it with cannabis essentially doubles down on the reflux risk.
Cottonmouth Is More Than an Annoyance
The dry mouth that cannabis reliably causes is relevant to acid reflux in a way most people don’t consider. Saliva is slightly alkaline, and every time you swallow, it helps neutralize small amounts of acid that have crept into the esophagus. This process, called acid clearance, is one of the esophagus’s main defense mechanisms. When saliva production drops, acid that reaches the esophageal lining sits there longer, doing more damage per episode. Cannabis consistently reduces salivary flow, and for someone who already has reflux, that means each reflux event is potentially more harmful than it would be without the dry mouth.
How Esophageal Peristalsis Fits In
Separate from the sphincter itself, the esophagus uses coordinated muscle contractions (peristalsis) to push swallowed food downward and to clear any refluxed acid. Research into cannabinoid receptors in the esophagus has explored what happens to peristalsis when the endocannabinoid system is manipulated. One study using rimonabant, a CB1 receptor blocker, found that blocking CB1 receptors significantly increased the duration of peristaltic contractions without changing their amplitude.9PubMed. Effect of rimonabant on oesophageal motor function in man The implication is that activating CB1 (which is what THC does) may have the opposite effect: shorter, potentially less effective peristaltic contractions. Weaker peristalsis means the esophagus is slower to clear acid after a reflux event, compounding the damage from each episode.
Both CB1 and CB2 receptors, along with a third receptor called GPR55, have been identified throughout the GI tract, though research specifically on how cannabinoids affect esophageal function remains limited.10PubMed Central. Review: The Role of Cannabinoids on Esophageal Function-What We Know Thus Far Most of the work on gut cannabinoid receptors focuses on the intestines and colon, so the esophagus is something of a blind spot in the field.
Cannabinoid Hyperemesis Syndrome and Acid Damage
Heavy, daily cannabis users face an additional reflux-adjacent risk that lighter users don’t: cannabinoid hyperemesis syndrome, or CHS. It involves cycles of severe nausea and vomiting, often with abdominal pain, interspersed with periods of relative well-being. The episodes typically decrease or stop when cannabis use is discontinued.11PubMed. Cannabinoid hyperemesis syndrome: definition, pathophysiology, clinical spectrum, insights into acute and long-term management Repeated forceful vomiting exposes the esophageal lining to stomach acid far beyond what normal reflux does, and it can lead to erosive esophagitis or even small tears in the esophageal wall.
CHS is more common than many clinicians initially assumed, partly because patients often don’t mention cannabis use to their doctors and partly because the condition was only formally recognized relatively recently. If you’re a daily cannabis user experiencing worsening reflux symptoms along with episodes of intense nausea and vomiting, especially if hot showers bring temporary relief, CHS is worth considering. The condition resolves with cessation of cannabis and does not respond to standard anti-nausea medications.
Do Edibles Avoid the Problem?
Switching from smoking to edibles removes the inhalation-related risks: no hot smoke, no coughing-induced pressure spikes, no direct aerosol exposure to the esophageal lining. That’s a meaningful improvement if you’re going to use cannabis regardless. But it doesn’t eliminate the pharmacological effects of THC on sphincter pressure, gastric emptying, saliva production, or peristalsis. Those effects come from the drug itself, not the delivery method.
Edibles may actually pose a unique reflux wrinkle of their own. They’re processed through the liver, producing 11-hydroxy-THC, which is more potent and longer-lasting than inhaled THC. This means the effects on gut motility and sphincter tone may persist for several hours rather than the shorter window from smoking. There’s no direct study comparing reflux outcomes between smoked and ingested cannabis, but the extended duration of action is worth thinking about, especially if your reflux tends to worsen at night. Taking an edible in the evening could mean your sphincter pressure and gastric motility are still suppressed when you lie down to sleep, which is exactly when gravity stops helping keep acid where it belongs.
Interactions with Reflux Medications
If you’re taking medication for GERD, cannabis adds a pharmacological variable that often goes undiscussed. THC is broken down primarily by two liver enzymes, CYP3A4 and CYP2C9, which are the same enzymes involved in metabolizing many common medications.12PubMed Central. Potential Adverse Drug Events with Tetrahydrocannabinol (THC) Due to Drug-Drug Interactions Some proton pump inhibitors (PPIs) are also processed through these pathways. When THC competes for the same enzymes, it can alter how quickly or slowly your reflux medication is metabolized, potentially changing its effectiveness. This isn’t a dramatic, dangerous interaction for most people, but it’s one more reason to mention cannabis use to a doctor managing your reflux.
Pain Perception and the Comfort Trap
Cannabinoids, especially those acting on CB2 receptors, have documented effects on visceral pain perception. The endocannabinoid system is often more active in areas of chronic inflammation, and cannabinoid agonists can reduce the sensation of pain from internal organs.13ScienceDirect / Academic Press. Handbook of Cannabis and Related Pathologies, Chapter 45 – Cannabis, Cannabinoids, and Visceral Pain For a reflux sufferer, this might sound appealing: less burning, less discomfort. But pain serves a purpose. Heartburn is the signal that acid is damaging your esophageal lining. If cannabis dulls that signal while the acid exposure continues or worsens, you might feel better while the underlying damage progresses. The epidemiological finding that cannabis users have higher rates of Barrett’s esophagus is consistent with this possibility: people may be tolerating reflux they would otherwise treat because the symptoms are masked.3PubMed Central. Marijuana Use as a Lifestyle Factor Associated With Gastroesophageal Reflux Disease (GERD) Complications
This creates a kind of comfort trap. Cannabis makes the reflux feel less bothersome, which reduces motivation to address it with lifestyle changes or medication, while the underlying acid exposure continues to damage esophageal tissue. Over years, that combination could meaningfully increase the risk of progressing from uncomplicated reflux to erosive esophagitis or Barrett’s.
What the Research Still Cannot Tell You
The honest state of the science is that nobody has run a randomized controlled trial giving some GERD patients cannabis and others a placebo and then tracking reflux outcomes over months. The lab studies use single doses in healthy volunteers or animals. The epidemiological studies use hospital discharge codes, which capture the heaviest users (sick enough to be admitted) and miss mild or moderate users entirely. There is almost no data comparing different strains, THC-to-CBD ratios, or consumption methods head to head for reflux outcomes.
CBD in particular is a conspicuous gap. It doesn’t activate CB1 receptors the way THC does, and it has anti-inflammatory properties that could theoretically benefit an inflamed esophagus. But “theoretically” is doing heavy lifting there. No published study has measured CBD’s effect on esophageal sphincter pressure, peristalsis, or reflux frequency in humans. Anyone claiming that CBD-dominant products are safe or beneficial for GERD is extrapolating well beyond the available evidence.
What the existing data does support is a pattern: short-term, single-dose THC can reduce one key reflux trigger, but chronic real-world cannabis use is associated with worse reflux outcomes across multiple mechanisms. The inhalation route adds its own damage. And the analgesic effect may hide symptoms while the problem deepens. For someone dealing with acid reflux, that combination of findings is worth taking seriously, even if the final word from a well-designed clinical trial hasn’t arrived yet.